Dynamic contrast-enhanced MRI parameters monitor and predict outcome of targeted radionuclide therapy in patients with neuroendocrine tumour liver metastases

K. Miyazaki, M. R. Orton, J. A. d'Arcy, V. Lewington, M. O. Leach, D. J. Collins, and D-M. Koh CR-UK and EPSRC Cancer Imaging Centre, The Institute of Cancer Research and Royal Marsden Hospital, Sutton, Surrey, United Kingdom, Department of Nuclear Medicine, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom, Department of Radiology, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom